In the Blue Corner… FTC comes out swinging on product switching

Louise Beange has written an interesting post on our sister blog In Competition about an ‘amicus brief’ issued by the US Federal Trade Commission (FTC) indicating that an incident of ‘product switching’ in the pharmaceutical industry by Warner Chilcott may be a breach of anti-trust laws.  Read more about it here.

We’ve previously posted about similar issues on IP Whiteboard here and here.

About the Author

Samantha McHugh
Samantha McHugh is a solicitor loving everything media, food, fashion and IP, who would like to get to pilates more frequently. With a penchant for mustard-coloured home furnishings and a mean repertoire of desserts, Sam has dreams of one day juggling a successful legal career with a chase for an endless summer around the globe. Sam also enjoys reality TV and online shopping to an extent which is unhealthy. Sam loves writing posts about branding, marketing, celebrities and anything that makes her giggle.
View all posts by Samantha McHugh